STEVEN KONICKI: Open Payments
NPI 1164512034 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$170 in 8 payments from 6 companies in 2025. Trend: 2023 $626 · 2024 $930 · 2025 $170
Food & beverage: $170
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $65 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Dexcom, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
Products named: Ozempic, ELIQUIS, VAXNEUVANCE, Dexcom G6 Transmitter, Wegovy, FARXIGA, QULIPTA.
Industry payments across MI — which companies pay providers there.
